Retatrutide (also known by its development code LY3437943) is one of the more widely discussed peptides in current metabolic research. This article covers the basics of what it is, structurally, and how it fits into the broader landscape of triple agonist peptide research.
What is Retatrutide?
Retatrutide is a synthetic peptide designed as a triple receptor agonist, meaning it's engineered to interact with three distinct receptor pathways rather than one. It is supplied as a lyophilised powder and typically reconstituted with bacteriostatic water before use in a research setting.
Why it's of research interest
Single and dual receptor agonist peptides have been studied extensively in metabolic research. Triple agonist compounds like retatrutide represent a newer generation of research interest, as they allow researchers to study the combined effects of engaging multiple pathways simultaneously, compared to single-target compounds.
Sourcing considerations
Because retatrutide is a complex synthetic peptide, sourcing quality matters. Key things to check when sourcing any batch:
- HPLC-verified purity (99%+ is the standard to look for)
- Correct molecular weight confirmation
- Proper storage and shipping to preserve peptide integrity
ASPeptides supplies Retatrutide 20mg, manufactured and HPLC verified by our supplier to a 99%+ purity standard. View the product page for full details.
This article is provided for laboratory research reference only. Retatrutide is not approved for human or veterinary use, and all products sold by ASPeptides are strictly for laboratory research use.